Simplex Trading, LLC Arbutus Biopharma Corp Transaction History

Simplex Trading, LLC

$3.35 Billion
Q1 2024

A detailed history of Simplex Trading, LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Simplex Trading, LLC holds 88,130 shares of ABUS stock, worth $287,303. This represents 0.01% of its overall portfolio holdings.

Number of Shares

88,130

Previous 104,460 15.63%

Holding current value

$287,303

Previous $261,000 13.03%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$2.26 - $2.92 $36,905 - $47,683	-16,330 Reduced 15.63%	88,130 $227,000
Q4 2023 Feb 02, 2024	BUY	$1.69 - $2.54 $133,626 - $200,835	79,069 Added 311.41%	104,460 $261,000
Q3 2023 Nov 01, 2023	SELL	$1.9 - $2.27 $6,653 - $7,949	-3,502 Reduced 12.12%	25,391 $51,000
Q2 2023 Aug 04, 2023	BUY	$2.24 - $3.06 $53,677 - $73,326	23,963 Added 486.06%	28,893 $66,000
Q1 2023 Apr 27, 2023	SELL	$2.23 - $3.1 $91,608 - $127,348	-41,080 Reduced 89.28%	4,930 $14,000

Q4 2022 Feb 02, 2023	BUY	$1.91 - $2.85 $10,417 - $15,543	5,454 Added 13.45%	46,010 $107,000
Q3 2022 Nov 04, 2022	SELL	$1.88 - $2.88 $167,009 - $255,844	-88,835 Reduced 68.66%	40,556 $77,000
Q2 2022 Aug 03, 2022	SELL	$1.98 - $3.17 $837 - $1,340	-423 Reduced 0.33%	129,391 $350,000
Q1 2022 May 02, 2022	SELL	$2.42 - $3.98 $174,600 - $287,153	-72,149 Reduced 35.72%	129,814 $386,000
Q4 2021 Feb 23, 2022	BUY	$3.11 - $4.61 $534,671 - $792,551	171,920 Added 572.25%	201,963 $785,000
Q3 2021 Oct 28, 2021	BUY	$2.65 - $4.62 $659 - $1,150	249 Added 0.84%	30,043 $94,000
Q2 2021 Aug 12, 2021	BUY	$2.5 - $3.51 $34,597 - $48,574	13,839 Added 86.74%	29,794 $90,000
Q1 2021 Apr 26, 2021	SELL	$3.14 - $4.84 $318,019 - $490,195	-101,280 Reduced 86.39%	15,955 $0
Q4 2020 Feb 02, 2021	BUY	$2.76 - $4.97 $323,568 - $582,657	117,235 New	117,235 $416,000
Q1 2020 Apr 29, 2020	SELL	$1.01 - $3.42 $43,777 - $148,236	-43,344 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$0.87 - $2.89 $37,344 - $124,053	42,925 Added 10244.63%	43,344 $120,000
Q3 2019 Oct 15, 2019	SELL	$1.34 - $2.4 $337 - $604	-252 Reduced 37.56%	419 $0
Q2 2019 Jul 26, 2019	BUY	$1.46 - $4.44 $979 - $2,979	671 New	671 $1,000
Q4 2018 Jan 16, 2019	SELL	$3.5 - $9.66 $26,950 - $74,382	-7,700 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$7.85 - $12.35 $14,530 - $22,859	-1,851 Reduced 19.38%	7,700 $72,000
Q2 2018 Jul 30, 2018	BUY	$5.0 - $7.35 $12,600 - $18,522	2,520 Added 35.84%	9,551 $69,000
Q1 2018 Apr 26, 2018	BUY	$4.4 - $6.05 $18,647 - $25,639	4,238 Added 151.74%	7,031 $35,000
Q4 2017 Jan 10, 2018	BUY	$4.45 - $7.7 $12,428 - $21,506	2,793	2,793 $14,000

Others Institutions Holding ABUS

# of Institutions

130

Shares Held

82.2M

Call Options Held

4.82M

Put Options Held

546K

View Full List

About Arbutus Biopharma Corp

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $489M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

More about ABUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Arbutus Biopharma Corp Transaction History